title: Meningococcal disease.
authors.affiliation: Meningitis and Special Pathogens Branch, Division of Bacterial and Myocotic Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA. nar5@cdc.gov
authors.forename: N E
authors.initials: NE
authors.lastname: Rosenstein
authors.forename: B A
authors.initials: BA
authors.lastname: Perkins
authors.forename: D S
authors.initials: DS
authors.lastname: Stephens
authors.forename: T
authors.initials: T
authors.lastname: Popovic
authors.forename: J M
authors.initials: JM
authors.lastname: Hughes
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D019072:Antibiotic Prophylaxis; D002462:Cell Membrane; D004196:Disease Outbreaks; D014943:Global Health; D006801:Humans; D008589:Meningococcal Infections / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control; D022401:Meningococcal Vaccines; D009345:Neisseria meningitidis / Q000145:classification / Q000648:ultrastructure; D012307:Risk Factors; D012703:Serotyping; D014481:United States / Q000453:epidemiology; D018074:Vaccines, Conjugate
chemical_list: D000900:Anti-Bacterial Agents; D022401:Meningococcal Vaccines; D018074:Vaccines, Conjugate